deltatrials
Terminated PHASE1 NCT00879073

Study Bendamustine Concurrent Whole Brain Radiation Brain Metastases From Solid Tumors

Phase I Study of Bendamustine With Concurrent Whole Brain Radiation Therapy in Patients With Brain Metastases From Solid Tumors

Sponsor: Cephalon

Conditions Brain Metastases
Interventions Bendamustine
Updated 6 times since 2017 Last updated: Dec 17, 2012 Started: Apr 30, 2009 Primary completion: Nov 30, 2012 Completion: Dec 31, 2012

A PHASE1 clinical study on Brain Metastases, this trial is terminated or withdrawn. The trial is conducted by Cephalon and has accumulated 6 data snapshots since 2009. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Change History

6 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE1

  3. Jan 2021 — Jul 2024 [monthly]

    Terminated PHASE1

  4. Jun 2018 — Jan 2021 [monthly]

    Terminated PHASE1

  5. Feb 2017 — Jun 2018 [monthly]

    Terminated PHASE1

▶ Show 1 earlier version

  1. Jan 2017 — Feb 2017 [monthly]

    Terminated PHASE1

    First recorded

Apr 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Cephalon
  • H. Lee Moffitt Cancer Center and Research Institute
  • National Comprehensive Cancer Network
Data source: H. Lee Moffitt Cancer Center and Research Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Tampa, United States